T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications
AbstractInvasive candidiasis is a common healthcare-associated infection with a high mortality rate that can exceed 60% in cases of septic shock. Blood culture performance is far from ideal, due to the long time to positivity and suppression by antifungal agents. The T2 Magnetic Resonance (T2MR) assay is an FDA-approved qualitative molecular diagnostic method that can detect and speciate the 5 most common Candida spp.; namely, Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Candida krusei, in approximately 5 h. In a multicenter clinical trial that included both a prospective and a contrived arm to represent the full range of clinically relevant concentrations of Candida spp., T2MR demonstrated a sensitivity and specificity of 91.1% and 98.1%, respectively. The utility of T2MR in candidemia depends on the prevalence of disease in each clinical setting. In intensive care units and other high-prevalence settings, the incorporation of T2MR in diagnostic algorithms is very appealing. T2MR is expected to allow timely initiation of antifungal therapy and help with anti-fungal stewardship. In low-prevalence settings, the positive predictive value of T2MR might not be enough to justify initiation of antifungal treatment in itself. The performance of T2MR has not been studied in cases of deep-seated candidiasis. Despite some promising evidence in published clinical trials, further studies are needed to determine the performance of T2MR in invasive candidiasis without candidemia. Overall, experience with T2MR in everyday clinical practice is evolving but, in the right setting, this technology is expected to provide “actionable information” for the management of patients evaluated for candidemia. View Full-Text
- Supplementary File 1:
ZIP-Document (ZIP, 1050 KB)
Share & Cite This Article
Zacharioudakis, I.M.; Zervou, F.N.; Mylonakis, E. T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications. J. Fungi 2018, 4, 45.
Zacharioudakis IM, Zervou FN, Mylonakis E. T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications. Journal of Fungi. 2018; 4(2):45.Chicago/Turabian Style
Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Mylonakis, Eleftherios. 2018. "T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications." J. Fungi 4, no. 2: 45.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.